HomeInsightsEPS

Glenmark Pharmaceuticals Ltd EPS

Glenmark Pharmaceuticals Ltd EPS

stocks purchased

₹ 5.1 Cr

Volume Transacted

(Nov 13, 2024)

stocks purchased

33.3 K

Stocks Traded

(Nov 13, 2024)

Last Updated on: Nov 14, 2024

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

EPS

₹ -80.43

Last updated on: Nov 13, 2024

Key Highlights

  • The Earning per Share of Glenmark Pharmaceuticals Ltd is ₹ -80.43 as of 13 Nov 24.
  • The Earning per Share of Glenmark Pharmaceuticals Ltd changed from ₹ 6.82 to ₹ 12.06 over 9 quarters. This represents a CAGR of 28.83% .

Historical Earning per Share of Glenmark Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Market Cap

43,414 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

5.5

Day’s High *

1574.65

Day’s Low

1522.8

DTE *

0.2

ROE *

-36.5

52 Week High

1830.05

52 Week Low

725.45

ROCE *

15.1

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 Nov 20241538.5
12 Nov 20241577.25
11 Nov 20241634.7
08 Nov 20241665.5
07 Nov 20241657.7
06 Nov 20241768.95
05 Nov 20241724.9
04 Nov 20241700.15
01 Nov 20241690.95
31 Oct 20241693.3

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glenmark Pharmaceuticals Ltd

Market Value

43,415

Asset Value

8,478

4.1 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd gains for third straight session

Glenmark Pharmaceuticals Ltd gained for a third straight session today. The stock is quoti...

Read more

06 Nov 202413:05

News

Glenmark Pharmaceuticals declare Quarterly Result

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

Read more

31 Oct 202412:07

News

Glenmark Pharmaceuticals Ltd spurts 2.21%

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

08 Oct 202413:05

News

Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...

Read more

23 Sep 202410:12

News

Glenmark Pharma successful concludes USFDA inspection of its Aurangabad unit

Glenmark Pharmaceuticals announced that the United States Food & Drug Administration (USFD...

Read more

21 Sep 202412:53

News

Glenmark Pharma's Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the USF...

Read more

21 Sep 202416:30

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

Sep 2023

PPT

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

May 2021

PPT

FAQs for EPS of Glenmark Pharmaceuticals Ltd

What is the EPS of Glenmark Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Glenmark Pharmaceuticals Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Glenmark Pharmaceuticals Ltd EPS calculated?

The EPS of Glenmark Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glenmark Pharmaceuticals Ltd report its EPS?

Glenmark Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glenmark Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Glenmark Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glenmark Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Glenmark Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*